Patient-reported outcomes in acute myeloid leukemia: Where are we now?
Outcomes for acute myeloid leukemia remain poor, and treatment decisions must consider not just quantity, but also quality of life (QOL). We conducted a systematic review of studies in patients with acute myeloid leukemia or high-risk myelodysplastic syndrome that incorporated patient-reported outcome (PRO) measures. PubMed and PsycINFO were searched for articles published from January 2000 through June 2016. Forty-one were relevant for our review with more published in recent years. There was considerable inter-study heterogeneity in which instruments were used, and many studies employed multiple (often overlapping) instruments.
Source: Blood Reviews - Category: Hematology Authors: Sarah A. Buckley, Kedar Kirtane, Roland B. Walter, Stephanie J. Lee, Gary H. Lyman Tags: Review Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Hematology | Leukemia | Myelodysplastic Syndrome | Study